UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012373
Receipt number R000014461
Scientific Title A phase II clinical trial of carbon-ion radiotherapy for patients with bone and soft tissue sarcomas not suited for surgical resection(HIMAT1341)
Date of disclosure of the study information 2013/12/01
Last modified on 2018/10/24 17:21:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II clinical trial of carbon-ion radiotherapy for patients with bone and soft tissue sarcomas not suited for surgical resection(HIMAT1341)

Acronym

Carbon-ion radiotherapy for bone and soft tissue sarcomas (HIMAT1341)

Scientific Title

A phase II clinical trial of carbon-ion radiotherapy for patients with bone and soft tissue sarcomas not suited for surgical resection(HIMAT1341)

Scientific Title:Acronym

Carbon-ion radiotherapy for bone and soft tissue sarcomas (HIMAT1341)

Region

Japan


Condition

Condition

bone and soft tissue sarcomas not suited for surgical resection

Classification by specialty

Orthopedics Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy and safety of carbon-ion radiotherapy for bone and soft tissue sarcomas not suited for surgical resection

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

two year local control rate

Key secondary outcomes

survival rate, progression free survival, complication rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Carbon-ion radiotherapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Histolocgically proven primary bone and soft tissue sarcomas
2) Unresectable tumor or patient's refusal of surgery
3) Not exceeding 15cm in tumor size
4) Measurable tumor
5) Age between 16 and 80 years old
6) PS 0-3
7) No distant metastasis
8) Expected to survival more than 6 months
9) Informed consent by patient

Key exclusion criteria

1) Located in Head
2) Past history of irradiation to the target
3) Past history of chemotherapy within 2 weeks before treatment
4) Active double cancers
5) Uncontrolled infectious disease
6) Artifact affecting dose calculation
7) Other medical or psychological unsuitable reasons

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiyuki Shioyama

Organization

SAGA HIMAT Foundation

Division name

Ion Bean Therapy Center

Zip code


Address

415, Harakoga-machi, Tosu, Saga, 841-0077

TEL

0942-81-1897

Email

shioyama-yoshiyuki@saga-himat.jp


Public contact

Name of contact person

1st name
Middle name
Last name Terashima Kotaro

Organization

SAGA HIMAT Foundation

Division name

Ion Bean Therapy Center

Zip code


Address

415, Harakoga-machi, Tosu, Saga, 841-0077

TEL

0942-81-1897

Homepage URL


Email

terashima-kotaro@saga-himat.jp


Sponsor or person

Institute

Ion Bean Therapy Center, SAGA HIMAT Foundation

Institute

Department

Personal name



Funding Source

Organization

No

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2013 Year 08 Month 26 Day

Date of IRB


Anticipated trial start date

2013 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective study


Management information

Registered date

2013 Year 11 Month 21 Day

Last modified on

2018 Year 10 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014461


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name